BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2023 Earnings Call Transcript

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2023 Earnings Call Transcript November 14, 2023 BioXcel Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.72 EPS, expectations were $-1.29. Operator: Good morning, and welcome to the BioXcel Therapeutics Conference Call, which will cover its alignment with the FDA on its TRANQUILITY program, provide an update on strategic […]

Related Keywords

Qatar ,United States ,America ,Vimal Mehta ,Greg Harrison ,Richard Steinhart ,Columbia University ,Qatar Investment Authority ,White House Office Of National Drug Control ,Oaktree Capital Management ,Qatar Investment ,Oaktree Capital ,White House Office ,National Drug Control ,Xcel Therapeutics ,Hedge Funds ,Their Top Stock Picks ,With The Largest Foreign Reserves ,Tranquility ,Bimal Mehta ,Financial Results ,Perator Instructions ,Meeting Minutes ,Fda ,Dr Mehta ,Herapeutics ,